|
Nobivac DHPPi
|
-
|
V/NRP/93/0047
|
Intervet International B.V., Nīderlande
|
QI07AD04
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Live Canine parainfluenza virus (CPi) strain Cornell,Live Canine adenovirus type 2 (CAV2), strain Manhattan LPV3,Live Canine distemper virus (CDV) strain Onderstepoort,Live Canine parvovirus (CPV), strain 154
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet International Booxmer, Nīderlande;Intervet International B.V., Nīderlande
|
| Date of authorisation/renewal: |
18-Aug-2008
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (24-Apr-2024)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (24-Apr-2024)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (24-Apr-2024)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/93/0047-01 |
|
5 |
Stikla flakons; satur liofilizētu granulu, 1 deva |
-
|
| V/NRP/93/0047-02 |
|
10 |
Stikla flakons; satur liofilizētu granulu, 1 deva |
-
|
| V/NRP/93/0047-03 |
|
25 |
Stikla flakons; satur liofilizētu granulu, 1 deva |
-
|
| V/NRP/93/0047-04 |
|
50 |
Stikla flakons; satur liofilizētu granulu, 1 deva |
-
|
|
|
Porcilis M Hyo ID Once
|
-
|
V/DCP/11/0071
|
Intervet International B.V., Nīderlande
|
QI09AB13
|
pigs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/11/0071-04 |
|
1 |
Stikla flakons, 50 deva |
-
|
| V/DCP/11/0071-05 |
|
5 |
Stikla flakons, 50 deva |
-
|
| V/DCP/11/0071-06 |
|
10 |
Stikla flakons, 50 deva |
-
|
| V/DCP/11/0071-07 |
|
1 |
Stikla flakons, 100 deva |
-
|
| V/DCP/11/0071-08 |
|
5 |
Stikla flakons, 100 deva |
-
|
| V/DCP/11/0071-09 |
|
10 |
Stikla flakons, 100 deva |
-
|
| V/DCP/11/0071-10 |
|
1 |
Polietilēna flakons, 100 deva |
-
|
| V/DCP/11/0071-11 |
|
5 |
Polietilēna flakons, 100 deva |
-
|
| V/DCP/11/0071-12 |
|
10 |
Polietilēna flakons, 100 deva |
-
|
|
|
Nobilis IB Ma5
|
-
|
V/NRP/00/1185
|
Intervet International BV, Nīderlande
|
QI01AA03
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate for oculonasal suspension/use in drinking water
|
| International name (active substance): |
Avian infectious bronchitis virus, type Massachusetts, strain Ma5, Live
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet International B.V., Nīderlande
|
| Date of authorisation/renewal: |
09-Mar-2010
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (03-Jul-2024)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (03-Jul-2024)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (03-Jul-2024)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/00/1185-01 |
|
10 |
Flakons, 1000 deva |
-
|
| V/NRP/00/1185-02 |
|
10 |
Flakons, 2500 deva |
-
|
| V/NRP/00/1185-03 |
|
10 |
Flakons, 5000 deva |
-
|
| V/NRP/00/1185-04 |
|
10 |
Flakons, 10000 deva |
-
|
| V/NRP/00/1185-07 |
|
10 |
Kausiņš, 10000 deva |
-
|
| V/NRP/00/1185-08 |
|
10 |
Kausiņš, 5000 deva |
-
|
| V/NRP/00/1185-09 |
|
10 |
Kausiņš, 1000 deva |
-
|
| V/NRP/00/1185-10 |
|
10 |
Kausiņš, 2500 deva |
-
|
| V/NRP/00/1185-11 |
|
12 |
Kausiņš, 1000 deva |
-
|
| V/NRP/00/1185-12 |
|
12 |
Kausiņš, 2500 deva |
-
|
| V/NRP/00/1185-13 |
|
12 |
Kausiņš, 5000 deva |
-
|
| V/NRP/00/1185-14 |
|
12 |
Kausiņš, 10000 deva |
-
|
|
|
Nobilis Ma5 + Clone 30
|
-
|
V/NRP/95/0165
|
Intervet International B.V., Nīderlande
|
QI01AA10
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate for oculonasal suspension/use in drinking water
|
| International name (active substance): |
Avian infectious bronchitis virus, type Massachusetts, strain Ma5, Live, Live Newcastle Disease virus, strain Clone 30
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet International B.V., Nīderlande
|
| Date of authorisation/renewal: |
03-Aug-2010
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (29-Nov-2024)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (29-Nov-2024)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (29-Nov-2024)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/95/0165-02 |
|
10 |
Flakons, 1000 deva |
-
|
| V/NRP/95/0165-03 |
|
10 |
Flakons, 2500 deva |
-
|
| V/NRP/95/0165-04 |
|
6 |
Kausiņš, 1000 deva |
-
|
| V/NRP/95/0165-05 |
|
6 |
Kausiņš, 2500 deva |
-
|
| V/NRP/95/0165-06 |
|
6 |
Kausiņš, 5000 deva |
-
|
| V/NRP/95/0165-07 |
|
6 |
Kausiņš, 10000 deva |
-
|
| V/NRP/95/0165-08 |
|
12 |
Kausiņš, 1000 deva |
-
|
| V/NRP/95/0165-09 |
|
12 |
Kausiņš, 2500 deva |
-
|
| V/NRP/95/0165-10 |
|
12 |
Kausiņš, 5000 deva |
-
|
| V/NRP/95/0165-11 |
|
12 |
Kausiņš, 10000 deva |
-
|
|
|
Nobilis ND Clone 30
|
-
|
V/NRP/95/0175
|
Intervet International B.V., Nīderlande
|
QI01AD06
|
turkeys; chickens
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/95/0175-01 |
|
10 |
Flakons, 1000 deva |
-
|
| V/NRP/95/0175-02 |
|
10 |
Flakons, 2500 deva |
-
|
| V/NRP/95/0175-03 |
|
10 |
Flakons, 5000 deva |
-
|
| V/NRP/95/0175-04 |
|
12 |
Kausiņš, 1000 deva |
-
|
| V/NRP/95/0175-05 |
|
12 |
Kausiņš, 2500 deva |
-
|
| V/NRP/95/0175-06 |
|
6 |
Kausiņš, 10000 deva |
-
|
| V/NRP/95/0175-07 |
|
12 |
Kausiņš, 5000 deva |
-
|
|
|
Lincomycin-spectinomycin
|
-
|
V/NRP/97/0543
|
Alfasan Nederland BV, Nīderlande
|
QJ01FF52
|
pigs; sheep; goats; chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Lincomycin hydrohloride,Spectinomycin hydrochloride
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Alfasan International B.V., Nīderlande
|
| Date of authorisation/renewal: |
22-Sep-2008
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[DOCX] 13022026LI (13-Feb-2026)
|
| Labelling text: |
[DOC] 13022026M (13-Feb-2026)
|
| Summary of product characteristics: |
[DOC] 13022026ZA (13-Feb-2026)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/97/0543-01 |
|
1 |
Flakons, 100 ml |
-
|
| V/NRP/97/0543-02 |
|
1 |
Flakons, 50 ml |
-
|
| V/NRP/97/0543-03 |
|
1 |
Flakons, 250 ml |
-
|
|
|
Oxytetracycline 10%
|
100 mg/ml
|
V/NRP/97/0603
|
Alfasan Nederland BV, Nīderlande
|
QJ01AA06
|
cattle; pigs; sheep; goats; dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Oxytetracycline hydrochloride
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Alfasan International B.V., Nīderlande
|
| Date of authorisation/renewal: |
22-Sep-2008
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[DOCX] 13022026LI (13-Feb-2026)
|
| Labelling text: |
[DOCX] 13022026M (13-Feb-2026)
|
| Summary of product characteristics: |
[DOCX] 13022026ZA (13-Feb-2026)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/97/0603-04 |
100 mg/ml |
1 |
Stikla (tumša) flakons, 100 ml |
-
|
| V/NRP/97/0603-07 |
100 mg/ml |
12 |
Stikla (tumša) flakons, 100 ml |
-
|
|
|
Ampicillin 20%
|
200 mg/ml
|
V/NRP/05/1637
|
Alfasan Nederland BV, Nīderlande
|
QJ01CA01
|
cattle; pigs; dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Ampicillin trihydrate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Alfasan International B.V., Nīderlande
|
| Date of authorisation/renewal: |
30-Dec-2009
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[DOC] 13022026LI (13-Feb-2026)
|
| Labelling text: |
[DOC] 13022026M (13-Feb-2026)
|
| Summary of product characteristics: |
[DOC] 13022026ZA (13-Feb-2026)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/05/1637-01 |
200 mg/ml |
1 |
Stikla flakons, 100 ml |
-
|
|
|
Alfasan Eye Ointment
|
-
|
V/NRP/97/0541
|
Alfasan Nederland BV, Nīderlande
|
QS01AA01
|
dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
eye ointment
|
| International name (active substance): |
Chloramphenicol,A vitamin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Alfasan International B.V., Nīderlande
|
| Date of authorisation/renewal: |
22-Sep-2008
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[DOCX] 13022026LI (13-Feb-2026)
|
| Labelling text: |
[DOCX] 13022026M (13-Feb-2026)
|
| Summary of product characteristics: |
[DOCX] 13022026ZA (13-Feb-2026)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/97/0541-01 |
|
12 |
Tūbiņa, 4 g |
-
|
|
|
Betamox LA
|
150 mg/ml
|
V/NRP/96/0446
|
Norbrook Laboratories (Ireland) Limited, Īrija
|
QJ01CA04
|
cattle; pigs; sheep; dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Amoxicillin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Norbrook Manufacturing Limited, Īrija
|
| Date of authorisation/renewal: |
16-Apr-2008
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] 19122022LI (16-Apr-2026)
|
| Labelling text: |
[PDF] 201120M (16-Apr-2026)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (16-Apr-2026)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/96/0446-01 |
150 mg/ml |
1 |
Stikla flakons, 50 ml |
-
|
| V/NRP/96/0446-02 |
150 mg/ml |
1 |
Stikla flakons, 100 ml |
-
|
| V/NRP/96/0446-03 |
150 mg/ml |
1 |
Polietilēna flakons, 50 ml |
-
|
| V/NRP/96/0446-04 |
150 mg/ml |
1 |
Polietilēna flakons, 100 ml |
-
|
| V/NRP/96/0446-05 |
150 mg/ml |
1 |
Polietilēna flakons, 250 ml |
-
|
| V/NRP/96/0446-06 |
150 mg/ml |
1 |
Polietilēna flakons, 500 ml |
-
|
| V/NRP/96/0446-07 |
150 mg/ml |
1 |
Stikla flakons, 250 ml |
-
|
|
|
KETOPROCEN
|
150 mg/ml
|
V/DCP/26/0007
|
Cenavisa S.L, Spānija
|
QM01AE03
|
cattle; pigs; horses
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/26/0007-01 |
|
1 |
Stikla flakons, 100 ml |
-
|
| V/DCP/26/0007-02 |
|
1 |
Stikla flakons, 250 ml |
-
|
| V/DCP/26/0007-03 |
|
1 |
Polipropilēna flakons, 100 ml |
-
|
| V/DCP/26/0007-04 |
|
1 |
Polipropilēna flakons, 250 ml |
-
|
|
|
Norocillin
|
300 mg/ml
|
V/NRP/98/0806
|
Norbrook Laboratories (Ireland) Limited, Īrija
|
QJ01CE09
|
cattle; pigs; sheep
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/98/0806-01 |
300 mg/ml |
1 |
Stikla flakons, 50 ml |
-
|
| V/NRP/98/0806-02 |
300 mg/ml |
1 |
Stikla flakons, 100 ml |
-
|
|
|
Longosona
|
1 mg/ml
|
V/NRP/99/0934
|
Industrial Veterinaria, S.A. - Invesa, Spānija
|
QH02AB02
|
cattle; pigs; sheep; horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Dexamethasone isonicotinate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Industrial Veterinaria, S.A. - Invesa, Spānija
|
| Date of authorisation/renewal: |
30-Apr-2009
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] 71-230409LI (30-Apr-2009)
|
| Labelling text: |
[DOC] 23042009M (30-Apr-2009)
|
| Summary of product characteristics: |
[PDF] 71-230409ZA (30-Apr-2009)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/99/0934-01 |
1 mg/ml |
1 |
Stikla flakons, 10 ml |
-
|
| V/NRP/99/0934-02 |
1 mg/ml |
1 |
Stikla flakons, 50 ml |
-
|
|
|
Levamisol 100
|
100 mg/ml
|
V/NRP/97/0634
|
Industrial Veterinaria, S.A., Spānija
|
QP52AE01
|
cattle; pigs; sheep
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Levamisol
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Industrial Veterinaria, S.A. - Invesa, Spānija
|
| Date of authorisation/renewal: |
13-Jun-2008
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] 230210LI (26-Feb-2010)
|
| Labelling text: |
[DOC] 26022010 (26-Feb-2010)
|
| Summary of product characteristics: |
[PDF] 230210ZA (26-Feb-2010)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/97/0634-03 |
100 mg/ml |
1 |
Flakons, 100 ml |
-
|
| V/NRP/97/0634-04 |
100 mg/ml |
1 |
Flakons, 250 ml |
-
|
|
|
Hierrodexina
|
-
|
V/NRP/96/0447
|
Industrial Veterinaria, S.A., Spānija
|
QB03AE04
|
cattle; pigs; sheep
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Cobalt chloride, Cyanocobalamin, Ferric polysaccharide
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Industrial Veterinaria, S.A. - Invesa, Spānija
|
| Date of authorisation/renewal: |
21-May-2008
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] 230210LI (26-Feb-2010)
|
| Labelling text: |
[DOC] 230210M (26-Feb-2010)
|
| Summary of product characteristics: |
[PDF] 230210ZA (26-Feb-2010)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/96/0447-01 |
|
1 |
Flakons, 50 ml |
-
|
| V/NRP/96/0447-02 |
|
1 |
Flakons, 100 ml |
-
|
|
|
Jodofoam Endofoam A.U.V.
|
-
|
V/NRP/08/1595
|
Fortevit Kft., Ungārija
|
QG51AD30
|
cattle
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/08/1595-01 |
0,2 g/0,4 g |
10 |
Alumīnija baloniņš, 45,2 g |
-
|
|
|
Robexera
|
6 mg
|
V/DCP/25/0076
|
KRKA, d.d., Novo mesto, Slovēnija
|
QM01AH91
|
cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/25/0076-01 |
|
1 |
OPA/Al/PVH-Al blisteris, 6 tablete |
-
|
| V/DCP/25/0076-02 |
|
1 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0076-03 |
|
3 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0076-04 |
|
6 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
|
|
Kenocidin Spray and Dip
|
5 mg/ml
|
V/MRP/12/0019
|
Cid Lines NV, Beļģija
|
QD08AC02
|
dairy cows
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
teat dip / teat spray solution
|
| International name (active substance): |
Chlorhexidine digluconate
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Cid Lines NV, Beļģija
|
| Date of authorisation/renewal: |
03-Feb-2015
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
MRP
|
| Package leaflet: |
[PDF] 300115LI (03-Feb-2015)
|
| Labelling text: |
[DOCX] 26112021M (26-Nov-2021)
|
| Summary of product characteristics: |
[DOCX] 26112021ZA (26-Nov-2021)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/12/0019-01 |
5 mg/g |
1 |
Polietilēna konteiners, 1 l |
-
|
| V/MRP/12/0019-02 |
5 mg/g |
1 |
Polietilēna konteiners, 5 l |
-
|
| V/MRP/12/0019-03 |
5 mg/g |
1 |
Polietilēna konteiners, 10 l |
-
|
| V/MRP/12/0019-04 |
5 mg/g |
1 |
Polietilēna konteiners, 20 l |
-
|
| V/MRP/12/0019-05 |
5 mg/g |
1 |
Polietilēna konteiners, 25 l |
[JPG]
|
| V/MRP/12/0019-06 |
5 mg/g |
1 |
Polietilēna konteiners, 60 l |
-
|
| V/MRP/12/0019-07 |
5 mg/g |
1 |
Polietilēna konteiners, 200 l |
-
|
|
|
Virbactan
|
150 mg
|
V/MRP/05/1640
|
Virbac S.A., Francija
|
QJ51DE90
|
cattle
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
intramammary ointment
|
| International name (active substance): |
Cefquinome (as cefquinome sulfate)
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Virbac S.A., Francija;Intervet International GmbH, Vācija
|
| Date of authorisation/renewal: |
09-Jul-2009
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
MRP
|
| Package leaflet: |
[PDF] 171221LI (11-Oct-2023)
|
| Labelling text: |
[PDF] 171221M (11-Oct-2023)
|
| Summary of product characteristics: |
[DOCX] 171221ZA (11-Oct-2023)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/05/1640-01 |
150 mg |
4 |
Pilnšļirce, 1 deva |
[PDF]
|
| V/MRP/05/1640-02 |
150 mg |
20 |
Pilnšļirce, 1 deva |
[PDF]
|
| V/MRP/05/1640-03 |
150 mg |
60 |
Pilnšļirce, 1 deva |
[PDF]
|
| V/MRP/05/1640-04 |
150 mg |
24 |
Pilnšļirce, 1 deva |
[JPG]
[JPG]
[JPG]
[PDF]
|
| V/MRP/05/1640-05 |
150 mg |
120 |
Pilnšļirce, 1 deva |
[PDF]
|
|
|
Tramcoat
|
80 mg
|
V/DCP/24/0014
|
Alfasan Nederland BV, Nīderlande
|
QN02AX02
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/24/0014-01 |
|
1 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/24/0014-02 |
|
2 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/24/0014-03 |
|
3 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/24/0014-04 |
|
4 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/24/0014-05 |
|
5 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/24/0014-06 |
|
6 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/24/0014-07 |
|
7 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/24/0014-08 |
|
8 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/24/0014-09 |
|
9 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/24/0014-10 |
|
10 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/24/0014-11 |
|
12 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/24/0014-12 |
|
25 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
|